Literature DB >> 15188352

Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope.

Ludmila Prokunina1, Leonid Padyukov, Anna Bennet, Ulf de Faire, Björn Wiman, Jonathan Prince, Lars Alfredsson, Lars Klareskog, Marta Alarcón-Riquelme.   

Abstract

OBJECTIVE: To study the frequency of allele A of polymorphism PD-1.3 of the PDCD1 gene in patients with rheumatoid arthritis (RA) and its subsets, based on the presence of rheumatoid factor (RF) and the shared epitope (SE) alleles.
METHODS: A total of 1,175 patients with RA and 3,404 controls were genotyped for the PD-1.3 A/G polymorphism, which previously was identified as being involved in susceptibility to systemic lupus erythematosus (SLE) in patients of European descent.
RESULTS: We first detected a trend for association of allele A of the single-nucleotide polymorphism PD-1.3 with RA (P = 0.053, odds ratio [OR] 1.18, 95% confidence interval [95% CI] 0.99-1.41). To further clarify the nature of this association, patients with RA were divided into 4 groups according to the presence of RF and the SE alleles. Association was found only in the group of patients negative for both RF and the SE alleles (P = 0.0054 [corrected P = 0.015], OR 1.75, 95% CI 1.15-2.65).
CONCLUSION: Patients negative for both RF and the SE alleles showed association with the same allele that we previously identified as being involved in susceptibility to SLE. These results provide the first evidence of the involvement of the human PDCD1 gene in arthritis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188352     DOI: 10.1002/art.20280

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  53 in total

Review 1.  PD-1, gender, and autoimmunity.

Authors:  Ravi K Dinesh; Bevra H Hahn; Ram Pyare Singh
Journal:  Autoimmun Rev       Date:  2010-04-28       Impact factor: 9.754

Review 2.  Rethinking mechanisms of autoimmune pathogenesis.

Authors:  Shiv Pillai
Journal:  J Autoimmun       Date:  2013-06-25       Impact factor: 7.094

3.  Ethnic differences in allele frequency of autoimmune-disease-associated SNPs.

Authors:  Mikako Mori; Ryo Yamada; Kyoko Kobayashi; Reimi Kawaida; Kazuhiko Yamamoto
Journal:  J Hum Genet       Date:  2005-05-10       Impact factor: 3.172

4.  Analysis of RUNX1 binding site and RAPTOR polymorphisms in psoriasis: no evidence for association despite adequate power and evidence for linkage.

Authors:  P Stuart; R P Nair; G R Abecasis; I Nistor; R Hiremagalore; N V Chia; Z S Qin; R A Thompson; S Jenisch; M Weichenthal; J Janiga; H W Lim; E Christophers; J J Voorhees; J T Elder
Journal:  J Med Genet       Date:  2005-05-27       Impact factor: 6.318

Review 5.  The genetics of systemic lupus erythematosus: understanding how SNPs confer disease susceptibility.

Authors:  Marta E Alarcón-Riquelme
Journal:  Springer Semin Immunopathol       Date:  2006-09-09

6.  PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children.

Authors:  Ronghua Ni; Kenji Ihara; Kenichi Miyako; Ryuichi Kuromaru; Mika Inuo; Hitoshi Kohno; Toshiro Hara
Journal:  Hum Genet       Date:  2007-01-03       Impact factor: 4.132

7.  Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response.

Authors:  Yuxiang Rui; Tasuku Honjo; Shunsuke Chikuma
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

Review 8.  T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases.

Authors:  Eoin F McKinney; Kenneth Gc Smith
Journal:  Immunol Cell Biol       Date:  2016-11       Impact factor: 5.126

9.  Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population.

Authors:  Xiang Liu; Li-Hua Hu; Yi-Rong Li; Feng-Hua Chen; Yong Ning; Qun-Feng Yao
Journal:  Rheumatol Int       Date:  2009-12-12       Impact factor: 2.631

10.  Association of PDCD1 gene markers with susceptibility to thyroid cancer.

Authors:  M R Haghshenas; M H Dabbaghmanesh; A Miri; A Ghaderi; N Erfani
Journal:  J Endocrinol Invest       Date:  2016-12-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.